YUMAB announces new research & collaboration agreement with Merck

Braunschweig, July 22, 2019
YUMAB GmbH and Merck have signed a research and collaboration agreement today. Within the scope of this cooperation, Merck’s Healthcare business will complement its own drug discovery efforts by utilizing YUMAB’s expertise, its comprehensive antibody libraries and its established technology platform to generate novel therapeutic antibodies.

Read our press release: